Recruiting

Testing a wireless device to monitor brain fluid shunt function

Plain-English translation of NCT07050628 on ClinicalTrials.gov ↗ · Source last updated August 2026 · Translation generated August 2026 · How we translate trials

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

What is this trial?

This trial is testing a new wireless device designed to monitor how well your cerebrospinal fluid (CSF) shunt is working without needing surgery or needles. The device measures fluid flow through your shunt while you go about your normal day and sleep. Researchers want to see if this device can reliably track shunt function at home over time.

Currently, doctors have limited ways to check if a shunt is working properly without invasive tests or waiting for symptoms to appear. This device could help doctors catch shunt problems earlier and give patients and families peace of mind by allowing safe, continuous monitoring at home.

Do you qualify?

You likely qualify if…

you are between 5 and 21 years old
you have an existing brain fluid shunt that can be felt under your skin
you have either a stable shunt with no recent problems, or a newly revised shunt within the last week
you have healthy skin over the shunt area where the device would be placed
you or your parent/guardian can give informed consent to participate

You likely don't qualify if…

your shunt cannot be felt under the skin or is too deep (more than 4 millimeters)
you have an open wound or swelling where the device would be placed
you have had serious skin reactions to silicone-based adhesive bandages in the past
your doctor thinks you won't be able to reliably use the device at home without help
you are enrolled in another research study that might interfere with this one

What participation looks like

If you join this study, you will wear the wireless monitoring device on your chest (over your shunt area) during regular daily activities and sleep. The device is non-invasive and wireless, so it won't require needles or surgery. You or your caregiver will take measurements at home as instructed, and the research team will track how well the device works over time. The study involves two groups: those with a stable, long-standing shunt, and those who recently had shunt surgery.

AI-generated summary from trial data · Aug 27, 2026 · Not medical advice

Trial locations(2 sites)

United States

Rhaeos Inc., Chicago, Illinois

Virginia Commonwealth University Medical Center, Richmond, Virginia